Sleep is essential for mental and physical restoration. It is a cycle with two separate states: rapid eye movement (REM), the stage in which most dreaming occurs; and non-REM (NREM). Four stages of sleep take place during NREM: stage I, when the person passes from relaxed wakefulness; stage II, an early stage of light sleep; stages III and IV, which are increasing degrees of deep sleep. Most stage IV sleep (also called delta sleep), occurs in the first several hours of sleep. A period of REM sleep normally follows a period of NREM sleep.
Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX), a specialty pharmaceutical company, announced that it recently had a meeting with the U.S. Food & Drug Administration (FDA) relating to the over-the-counter (OTC) development program for Silenor®. In the meeting, which Somaxon attended jointly with its Silenor partner Procter & Gamble, the FDA provided clinical and regulatory guidance that the company believes provides a clear path forward toward an OTC version of Silenor.
Somaxon believes that the FDA�s guidance provides an opportunity to develop an OTC label that is tailored to Silenor�s clinical profile and differentiated from other OTC sleep products. Somaxon believes that Silenor�s characteristics, including its lack of addiction potential and its clinical efficacy and safety profile, make it an ideal candidate to be the first prescription insomnia product to be converted to an OTC product.
Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded products and late-stage product candidates to treat important medical conditions where there is an unmet medical need and/or high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Somaxon�s product Silenor, now available by prescription in the United States, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance.
For more information, please visit the company�s web site at www.somaxon.com.
support.com, Inc. (Nasdaq:SPRT) announced preliminary unaudited financial results for the quarter ending September 30, 2011. Support.com currently expects to report revenue in the range of $12.3 million to $12.6 million and a non-GAAP net loss per share in the range of $(0.10) to $(0.12). Non-GAAP results exclude stock-based compensation expense, amortization of intangible assets, restructuring and impairment charges, and acquisition expense.
Support.com, Inc. (NASDAQ: SPRT) provides cloud-based technology services and software for consumers and small business.
Cleantech Transit, Inc. (CLNO)
Biomass can be used for a variety of commercial activities. There are several technologies which employ direct combustion of unprocessed or semi-processed biomass to produce process heat for a variety of end-uses. The most common is the simple furnace and boiler system which raises steam for such applications such as tobacco curing, electricity generation and beer brewing. Biomass is also used for providing direct heat for brick burning, for lime burning and cement kilns. The advantage of using biomass is that it can be locally sourced, thereby avoiding shortages associated with poor fuel supply networks and fluctuating costs.
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project could benefit the Company’s manufacturing clients worldwide.
Cleantech Transit, Inc. (CLNO) is pleased to announce it has met its funding requirement to secure the Company’s ability to earn in 25% of the 500KW Merced Project.
The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.
For more information about Cleantech Transit, Inc. visit its website www.cleantechtransitinc.com
Streamline Health Solutions, Inc. (Nasdaq:STRM) announced that PeaceHealth, a regional healthcare system serving rural, suburban, and urban communities in Alaska, Washington, and Oregon, has signed an agreement through Streamline Health’s strategic partner, GE Healthcare, to upgrade to AccessAnyWare v5.1. As part of the agreement the solution will be implemented in PeaceHealth’s hospitals and clinics in 2012.
Streamline Health transforms unstructured documents, forms, and images into actionable digital assets that improve processes and revenue across the enterprise.
Blackboard Inc. (Nasdaq:BBBB) announced the launch of Blackboard Collaborate�, the only education-focused platform for real-time collaboration that helps institutions shift more learning, networking, and communication online to improve education quality while reducing the cost of academic operations.
Blackboard Inc. (Nasdaq:BBBB) is a global leader in enterprise technology and innovative solutions that improve the experience of millions of students and learners around the world every day.
No comments :
Post a Comment